NextCure, Inc. (NXTC)
6.88
+0.30
(+4.56%)
USD |
NASDAQ |
Oct 15, 16:00
7.09
+0.21
(+3.05%)
After-Hours: 20:00
NextCure Price : 6.88 for Oct. 15, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 6.593 | 7.22 | 6.593 | 6.88 | 72423.00 |
| Oct 14, 2026 | 6.16 | 6.858 | 6.11 | 6.58 | 51643.00 |
| Oct 13, 2026 | 6.58 | 6.80 | 6.21 | 6.28 | 54706.00 |
| Oct 12, 2026 | 7.08 | 7.52 | 6.03 | 6.64 | 130472.0 |
| Oct 09, 2026 | 6.675 | 7.20 | 6.30 | 7.18 | 85746.00 |
| Oct 08, 2026 | 6.24 | 6.94 | 6.048 | 6.78 | 82602.00 |
| Oct 07, 2026 | 5.70 | 6.72 | 5.42 | 6.56 | 109568.0 |
| Oct 06, 2026 | 5.01 | 5.905 | 5.00 | 5.685 | 122586.0 |
| Oct 05, 2026 | 5.05 | 5.19 | 4.94 | 5.05 | 14554.00 |
| Oct 02, 2026 | 5.17 | 5.40 | 4.85 | 5.09 | 63332.00 |
| Oct 01, 2026 | 4.99 | 5.19 | 4.850 | 4.96 | 46588.00 |
| Sep 30, 2026 | 5.14 | 5.165 | 4.91 | 5.01 | 34140.00 |
| Sep 29, 2026 | 5.00 | 5.22 | 4.78 | 4.845 | 55409.00 |
| Sep 28, 2026 | 5.02 | 5.305 | 5.00 | 5.08 | 63197.00 |
| Sep 25, 2026 | 5.27 | 5.56 | 5.023 | 5.08 | 71790.00 |
| Sep 24, 2026 | 4.80 | 5.650 | 4.80 | 5.28 | 226905.0 |
| Sep 23, 2026 | 5.12 | 5.19 | 4.64 | 4.82 | 225869.0 |
| Sep 22, 2026 | 5.59 | 5.90 | 4.87 | 5.18 | 156969.0 |
| Sep 21, 2026 | 6.09 | 6.30 | 5.32 | 5.46 | 126034.0 |
| Sep 18, 2026 | 5.87 | 6.27 | 5.67 | 6.12 | 103912.0 |
| Sep 17, 2026 | 6.05 | 6.38 | 5.54 | 5.67 | 106853.0 |
| Sep 16, 2026 | 6.55 | 6.63 | 5.765 | 6.03 | 106981.0 |
| Sep 15, 2026 | 6.65 | 6.735 | 6.06 | 6.37 | 157560.0 |
| Sep 14, 2026 | 6.82 | 7.00 | 6.200 | 6.64 | 90563.00 |
| Sep 11, 2026 | 7.33 | 7.78 | 6.88 | 7.00 | 115760.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 58.50 |
| Oncolytics Biotech, Inc. | 0.5476 |
| Sangamo Therapeutics, Inc. | 0.1409 |
| Sarepta Therapeutics, Inc. | 17.79 |
| Anixa Biosciences, Inc. | 2.78 |
Price Related Metrics
| Price to Book Value | 2.304 |
| Earnings Yield | -153.9% |
| Market Cap | 27.99M |